CN Patent

CN105622562B — 一种治疗心脑血管疾病的药物组合物

Assigned to Dongguan Asia Pharmaceutical Technology Co ltd · Expires 2017-12-29 · 8y expired

What this patent protects

本发明涉及一种治疗心脑血管疾病的药物组合物，所述药物组合物包含有效量的化合物和药学上可接受的载体，所述化合物具有下列结构：本发明的化合物对于心脑血管疾病的效果显著，可以开发成临床上有效的新的药物组合物。

USPTO Abstract

本发明涉及一种治疗心脑血管疾病的药物组合物，所述药物组合物包含有效量的化合物和药学上可接受的载体，所述化合物具有下列结构：本发明的化合物对于心脑血管疾病的效果显著，可以开发成临床上有效的新的药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number: CN105622562B
Jurisdiction: CN
Classification: —
Expires: 2017-12-29
Drug substance claim: No
Drug product claim: No
Assignee: Dongguan Asia Pharmaceutical Technology Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.